Valuation is essential for biotechnology companies to assess the worth of their intellectual property (e.g., patents, research), evaluate R&D investments, secure funding, negotiate licensing deals, and determine fair market value in mergers or acquisitions.

Valuation is essential for assessing the value of pharmaceutical manufacturing facilities, intellectual property, and production assets. It supports decision-making regarding facility expansion, mergers, and asset optimization.

Valuation is critical for assessing the financial health of healthcare providers, determining the value of medical facilities, and supporting healthcare system planning. It aids in budgeting, financial reporting, and merger evaluations.

Valuation is necessary for assessing the value of pharmaceutical patents, healthcare facilities, and the financial performance of healthcare organizations. It supports investment in research and development, mergers, and acquisitions.

Valuation is crucial for determining the market value of real estate assets, assessing rental income potential, and making informed investment decisions. It supports property acquisition, financing, and asset management.